title: Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus.
authors: Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA. mrr6@columbia.edu.
authors: Mishaela R
authors: MR
authors: Rubin
authors: Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
authors: Allison B
authors: AB
authors: Goldfine
authors: Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA.
authors: Donald J
authors: DJ
authors: McMahon
authors: Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA.
authors: Daniel S
authors: DS
authors: Donovan
authors: Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA.
authors: Serge
authors: S
authors: Cremers
authors: Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA.
authors: Elzbieta
authors: E
authors: Dworakowski
authors: Lipid Metabolism Laboratory, Tufts University, Boston, MA, USA.
authors: Ernst J
authors: EJ
authors: Schaefer
authors: Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
authors: Steven E
authors: SE
authors: Shoelson
authors: Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA.
authors: Shonni J
authors: SJ
authors: Silverberg
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D015415:Biomarkers / Q000097:blood; D016723:Bone Remodeling / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D015675:Osteocalcin / Q000187:drug effects*; D012459:Salicylates / Q000008:administration & dosage / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D012459:Salicylates; D015675:Osteocalcin; C014182:salicylsalicylic acid
references: Am J Epidemiol. 2007 Sep 1;166(5):495-505
references: 17575306
references: Nat Med. 2005 Feb;11(2):183-90
references: 15685173
references: J Clin Endocrinol Metab. 2009 Mar;94(3):827-32
references: 19088165
references: J Clin Endocrinol Metab. 2012 Sep;97(9):3240-50
references: 22740707
references: Osteoporos Int. 2002;13(2):171-5
references: 11905526
references: J Clin Endocrinol Metab. 2008 Dec;93(12):4804-9
references: 18796521
references: Ann Intern Med. 2010 Mar 16;152(6):346-57
references: 20231565
references: Diabetes. 1995 Jul;44(7):775-82
references: 7789645
references: Clin Transl Sci. 2008 May;1(1):36-43
references: 19337387
references: J Clin Endocrinol Metab. 2012 Apr;97(4):1277-84
references: 22337915
references: J Clin Invest. 2006 Jul;116(7):1793-801
references: 16823477
references: J Clin Endocrinol Metab. 2013 Jan;98(1):345-51
references: 23162093
references: Osteoporos Int. 2007 Apr;18(4):427-44
references: 17068657
references: Diabetes Metab Res Rev. 2018 May;34(4):e2991
references: 29430796
references: J Bone Miner Res. 2001 Feb;16(2):328-37
references: 11204433
references: Curr Pharm Des. 2001 May;7(8):613-35
references: 11375772
references: Nature. 1998 Nov 5;396(6706):77-80
references: 9817203
references: Nat Med. 2013 Mar;19(3):358-63
references: 23396210